Agilent Technologies, Inc. $A Shares Bought by Dudley & Shanley Inc.

Key Points

• Dudley & Shanley increased its Agilent Technologies stake by 25.9% in the second quarter, acquiring 14,300 additional shares for a total of 69,500 shares valued at approximately $9.23 million.
• Agilent reported quarterly earnings of $1.49 per share and $1.83 billion in revenue, beating analyst estimates, while revenue rose 10% year over year. The company maintained fiscal 2026 EPS guidance of $6.00–$6.10.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and a $159.35 price target; the stock recently traded at $146.04 and pays a quarterly dividend equivalent to a 0.7% annual yield.

Dudley & Shanley Inc. grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 25.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 69,500 shares of the medical research company's stock after buying an additional 14,300 shares during the period. Agilent Technologies accounts for about 1.4% of Dudley & Shanley Inc.'s investment portfolio, making the stock its 26th biggest holding. Dudley & Shanley Inc.'s holdings in Agilent Technologies were worth $9,232,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in A. Core Wealth Advisors LLC acquired a new position in shares of Agilent Technologies during the fourth quarter valued at $26,000. SHP Wealth Management acquired a new stake in Agilent Technologies in the fourth quarter worth about $26,000. Navalign LLC bought a new position in Agilent Technologies in the 4th quarter valued at about $27,000. Cedar Mountain Advisors LLC bought a new position in Agilent Technologies in the 1st quarter valued at about $27,000. Finally, MV Capital Management Inc. acquired a new position in Agilent Technologies during the 4th quarter valued at about $28,000.

Agilent Technologies Trading Up 0.0%

Agilent Technologies stock opened at $146.04 on Monday. The firm has a market cap of $41.25 billion, a price-to-earnings ratio of 29.32, a price-to-earnings-growth ratio of 2.59 and a beta of 1.25. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27. The firm's 50 day moving average price is $134.16 and its two-hundred day moving average price is $125.07. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company's revenue was up 10.0% compared to the same quarter last year. During the same period last year, the company posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts predict that Agilent Technologies, Inc. will post 6.01 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th were given a $0.255 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies's dividend payout ratio (DPR) is 20.48%.

Analyst Ratings Changes

A has been the topic of a number of recent analyst reports. Barclays boosted their price target on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 24th. Wolfe Research reiterated a "hold" rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. Robert W. Baird upped their target price on Agilent Technologies from $155.00 to $156.00 and gave the stock an "outperform" rating in a research report on Tuesday, May 26th. Sanford C. Bernstein began coverage on Agilent Technologies in a research report on Friday, June 26th. They issued an "outperform" rating and a $155.00 target price for the company. Finally, Wells Fargo & Company decreased their price target on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a research note on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, Agilent Technologies currently has a consensus rating of "Moderate Buy" and a consensus target price of $159.35.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source